Clinical trials
Cardiotoxicity trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| European Institute of Oncology | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Fondazione del Piemonte per l'Oncologia | 1 |
| Giulio Stefanini | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 13 |
| Breast Neoplasms | 4 |
| Lymphoma | 2 |
| Neoplasms | 2 |
| COVID-19 | 1 |
| Colorectal Neoplasms | 1 |
| Heart Diseases | 1 |
| Heart Failure | 1 |
| Hodgkin Disease | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.